4
Changes in Ownership
Aligos Therapeutics, Inc. Filed Acc 0001567619-20-018006
See Remarks acquired 18,517 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Symons Julian A. See Remarks | 2020-10-20 | Conversion | +13,671 | 389,218 | D | ||
| Symons Julian A. See Remarks | 2020-10-20 | Conversion | +3,394 | 392,612 | D | ||
| Symons Julian A. See Remarks | 2020-10-20 | Conversion | +1,452 | 394,064 | D | ||
| Derivatives | |||||||
| Symons Julian A. See Remarks | 2020-10-20 | Conversion · Series A Preferred Stock | −13,671 | 0 | D | ||
| Symons Julian A. See Remarks | 2020-10-20 | Conversion · Series B-1 Preferred Stock | −3,394 | 0 | D | ||
| Symons Julian A. See Remarks | 2020-10-20 | Conversion · Series B-2 Preferred Stock | −1,452 | 0 | D | ||
Loading xslF345X03/doc1.xml…